Perspective Therapeutics (CATX) Total Liabilities (2011 - 2026)

Perspective Therapeutics has disclosed Total Liabilities across 16 years of filings, most recently posting $63.3 million for Q1 2026.

• Total Liabilities for Q1 2026 came in at $63.3 million, up 41.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $63.3 million (up 41.67% YoY), and the FY2025 annual result was $59.9 million, up 18.85% from the prior year.
• Total Liabilities came in at $63.3 million for Q1 2026 at Perspective Therapeutics, up from $59.9 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $63.3 million in Q1 2026 to a low of $2.9 million in Q1 2022.
• The 5-year median for Total Liabilities is $44.7 million (2025), against an average of $31.9 million.
• Across the five-year window, Total Liabilities soared 558.51% in 2023 and dropped 16.07% in 2025, its largest moves.
• Perspective Therapeutics' Total Liabilities stood at $3.4 million in 2022, then jumped by 558.51% to $22.7 million in 2023, then soared by 122.05% to $50.4 million in 2024, then rose by 18.85% to $59.9 million in 2025, then increased by 5.66% to $63.3 million in 2026.
• The last three Total Liabilities figures came in at $63.3 million (Q1 2026), $59.9 million (Q4 2025), and $52.6 million (Q3 2025), per Business Quant data.